De Grève J - Search Results

1

High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects.

Goelen G, Teugels E, Bonduelle M, Neyns B, De Grève J. Goelen G, et al. Among authors: de greve j. J Med Genet. 1999 Apr;36(4):304-8. J Med Genet. 1999. PMID: 10227398 Free PMC article.

2

Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer.

Amfo K, Neyns B, Teugels E, Lissens W, Bourgain C, De Sutter P, Vandamme B, Vamos E, De Grève J. Amfo K, et al. Among authors: de greve j, de sutter p. Oncogene. 1995 Jul 20;11(2):351-8. Oncogene. 1995. PMID: 7624149

3

Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium.

Neyns B, Katesuwanasing, Vermeij J, Bourgain C, Vandamme B, Amfo K, Lissens W, DeSutter P, Hooghe-Peters E, DeGrève J. Neyns B, et al. Oncogene. 1996 Mar 21;12(6):1247-57. Oncogene. 1996. PMID: 8649827

4

Ethical aspects of genetic counseling in familial breast and ovarian cancer. Combining applied theory and reflective practice.

Goelen G, Rigo A, Neyns B, Betz W, De Grève J. Goelen G, et al. Among authors: de greve j. Ann N Y Acad Sci. 1997 Dec 29;833:170-2. doi: 10.1111/j.1749-6632.1997.tb48604.x. Ann N Y Acad Sci. 1997. PMID: 9616750 No abstract available.

5

Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines.

Zeinoun Z, Teugels E, De Bleser PJ, Neyns B, Geerts A, De Greve J. Zeinoun Z, et al. Among authors: de bleser pj, de greve j. Anticancer Res. 1999 Jan-Feb;19(1A):413-20. Anticancer Res. 1999. PMID: 10226576

6

Moral concerns of different types of patients in clinical BRCA1/2 gene mutation testing.

Goelen G, Rigo A, Bonduelle M, De Grève J. Goelen G, et al. Among authors: de greve j. J Clin Oncol. 1999 May;17(5):1595-600. doi: 10.1200/JCO.1999.17.5.1595. J Clin Oncol. 1999. PMID: 10334549

7

Alteration of jun proto-oncogene status by plasmid transfection affects growth of human ovarian cancer cells.

Neyns B, Teugels E, Bourgain C, Birrerand M, De Grève J. Neyns B, et al. Among authors: de greve j. Int J Cancer. 1999 Aug 27;82(5):687-93. doi: 10.1002/(sici)1097-0215(19990827)82:5<687::aid-ijc11>3.0.co;2-f. Int J Cancer. 1999. PMID: 10417766

8

BRCA 1/2 gene mutation testing-based cancer prevention and the moral concerns of different types of patients.

Goelen G, Rigo A, Bonduelle M, De Grève J. Goelen G, et al. Among authors: de greve j. Ann N Y Acad Sci. 1999;889:240-3. doi: 10.1111/j.1749-6632.1999.tb08740.x. Ann N Y Acad Sci. 1999. PMID: 10668499 No abstract available.

9

Moral issues in day-to-day palliative medicine and their relevance for the education of European general practitioners.

Goelen G, Rigo A, Fontaine C, Wanrooij B, De Grève J. Goelen G, et al. Among authors: de greve j. J Cancer Educ. 2001 Spring;16(1):12-4. doi: 10.1080/08858190109528716. J Cancer Educ. 2001. PMID: 11270892

10

Contaminants within bacterial plasmid preparations trigger apoptosis in liposome transfected OVCAR3, but not in SKOV3 or AZ224 human ovarian cancer cells.

Neyns B, De Rijcke M, Vermeij J, Teugels E, Zeinoun Z, De Grève J. Neyns B, et al. Among authors: de greve j, de rijcke m. Cell Biol Int. 2001;25(8):715-23. doi: 10.1006/cbir.2001.0767. Cell Biol Int. 2001. PMID: 11482895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters